Neuromed- Integrated Health Life Platform and Biobank

This project aims to create a digital platform for personal, clinical, diagnostic and environmental data collection, management and analysis of patients with cardiovascular and neurological disease or cancer admitted to the Neuromed Group clinics, associated with a biobanks of biological fluids and human tissues and a biotechnological platform for "omics" analysis, to encourage personalized, preventative and predictive care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Diseases Cancer Chronic Disease Disease Attributes Neoplasms Neuro-Degenerative Disease Pathologic Processes Pathological Conditions, Signs and Symptoms Pregnancy

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

IRCCS INM Neuromed, Department of Epidemiology and Prevention

Pozzilli, IS, 86077, Italy

About this study

There is a need for a change of vision in health care that could become a key innovation point for digital medicine in the future, a sort of Copernican revolution: the starting point is no longer the disease, but the patient around whom pathologies and risk factors rotate, not as distinct and uniquely defined entities, but as communicating and interconnected possibilities that define their form only in relation to the individual, his genome, his personality, his habits of life and the environment in which he lives. From these interactions, a personalized, dynamic, integrated, and continuous diagnostic and therapeutic pathway is created that accompanies the person not only in the stage of the disease but also in the previous and subsequent phases, becoming a way of life oriented towards the health of the person rather than a way to cure a disease.

An Integrated Health Life Platform enables you to develop an interactive healthcare health model among all actors who manage the health of the person, healthcare professionals in the area, and hospitals, caregivers, and community through the integration of remote monitoring of data with A virtual community.

The platform is thought not as a pure aggregation of data, but as a digital hub centered on the patient, with his (clinical and personal) data, but also the environment in which he lives, his behaviors, accessibility to services and The relationships that come to them and from them. The platform aims to effectively integrate self management, personalization of the path, and co-production of health, demonstrating that these three key dimensions of care are mutually reinforcing.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men and women
Older than 18 years
Cardiovascular disease
neurodegenerative disease
Cancer
Pregnancy

Exclusion criteria

Inability to understand and to want
Refusal to sign the informed consent

Treatment and study plan

Primary outcomes

Biological sample bank

Time frame: baseline

A repository of biological samples, "Neurobiobank", from patients who will join the project, will be organised at the biotechnology park of Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed of Pozzilli under the responsibility of the experienced staff at the Department of Epidemiology and Prevention.
Integrated health-life big data platform

Time frame: baseline

Analytical tools will be developped for integrating structured and unstructured patients data sets and derive actionable information from their observed interrelationships.
omics analysis

Time frame: baseline

Measure of genomic, epigenetic and proteomic fingerprint of recruited patients
Four P (4P) medicine

Time frame: Baseline

Identification of patterns within the health data that correlate with disease or wellness and create personalised pathway of prevention and care.

Sponsors and collaborators

Lead sponsor

Neuromed IRCCS

Other

Registry information

Acronym: PLATONE

Important dates

Study start: 2019
Primary completion: 2023
Study completion: 2023
First posted: Sep 12, 2017
Registry last updated: Nov 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed